This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Synthetic Genomics Inc. Applauds The Venter Institute's Work In Creating The First Synthetic Bacterial Cell

LA JOLLA, Calif., May 20 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company applying synthetic genomic-driven commercial solutions to a variety of global challenges including energy and the environment, applauds the creation of the first synthetic bacterial cell by researchers at the J. Craig Venter Institute (JCVI). SGI has provided nearly $30 million in funding for this work since 2005.

SGI was founded in 2005 by Drs. J. Craig Venter and Hamilton Smith, along with business leaders Juan Enriquez and David Kiernan, to develop commercial applications based on the basic science research of JCVI's synthetic genomics group. The initial business focus of SGI has centered on bioenergy; however the company has now extended its focus to areas of food production, clean water and vaccine development. Many aspects of JCVI's synthetic genomics work have been integrated into the SGI business programs. SGI plans to revolutionize many industrial processes by designing new cells that synthesize the desired commercial products.  

"With the growing impact of climate change, increased global demand for energy, and the potential for environmental impact issues surrounding the drilling for oil and mining for coal, it is clear that new technologies are needed in these areas," said Ari Patrinos, SGI President. "Synthetic genomics research from JCVI and the applied science at SGI have the potential to address these issues."

SGI's alliance with Exxon Mobil Research and Engineering (EMRE) group to create algal biofuels is one example of the important programs at SGI that could benefit from the new tools and technological advances of the synthetic genomics research. This program, announced in July 2009, is a long term research and development alliance focused on finding and optimizing (through synthetic genome techniques and other more traditional metabolic engineering techniques) algae to produce biological crude oil replacements efficiently.

Dr. Venter and the SGI team, as world leaders in developing and driving this area of science, also believe that addressing the societal and ethical issues surrounding synthetic genomics are essential aspects in conducting this research. As such, he and the team have spent equal time focused on these issues in conjunction with and as an augment to the considerable work that has been done at JCVI since 1995. The research at JCVI has undergone significant review at the highest levels of science and government and SGI supports continued review and discussion of this growing area of science. Dr. Venter and the team have met with Congressional members several times since the company's formation to educate them on the field of synthetic genomics.  They have also conducted tours and outreach to state and local governments, have made presentations to many governmental agencies, and speak regularly to other groups (lay audiences, scientific groups, media, etc).

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,122.01 +15.31 0.09%
S&P 500 2,000.12 +0.10 0.00%
NASDAQ 4,569.6210 -1.0160 -0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs